Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Vox Sanguinis
|
April 9, 2008
Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma
V S Hornsey, O Drummond, L McMillan, et al.
Diabetologia
|
May 1, 1980
Plasma beta-thromboglobulin in diabetes mellitus
D Q Borsey, J Dawes, D M Fraser, et al.
Thrombosis and Haemostasis
|
August 30, 1985
Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies
V Hornsey, L R Micklem, M C McCann, et al.
Vox Sanguinis
|
December 24, 2010
Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion
V S Hornsey, C Casey, K McColl, et al.
Thrombosis Research
|
March 15, 1983
A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers
J Dawes, K J Clemetson, G O Gogstad, et al.
Vox Sanguinis
|
January 1, 1985
Macroaggregate formation in optimal additive red cells
M Robertson, F E Boulton, R Doughty, et al.
Vox Sanguinis
|
June 8, 2006
Extended storage of platelets in SSP platelet additive solution
V S Hornsey, K McColl, O Drummond, et al.
Journal of Clinical Pathology
|
June 1, 1984
Platelet and coagulation factors in proliferative diabetic retinopathy
D Q Borsey, C V Prowse, R S Gray, et al.
Thrombosis and Haemostasis
|
October 1, 1981
Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate
C V Prowse, B Griffin, D S Pepper, et al.
Vox Sanguinis
|
January 1, 1988
Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use
P R Foster, I H Dickson, T A McQuillan, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Vox Sanguinis
|
April 9, 2008
Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma
V S Hornsey, O Drummond, L McMillan, et al.
Diabetologia
|
May 1, 1980
Plasma beta-thromboglobulin in diabetes mellitus
D Q Borsey, J Dawes, D M Fraser, et al.
Thrombosis and Haemostasis
|
August 30, 1985
Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies
V Hornsey, L R Micklem, M C McCann, et al.
Vox Sanguinis
|
December 24, 2010
Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion
V S Hornsey, C Casey, K McColl, et al.
Thrombosis Research
|
March 15, 1983
A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers
J Dawes, K J Clemetson, G O Gogstad, et al.
Vox Sanguinis
|
January 1, 1985
Macroaggregate formation in optimal additive red cells
M Robertson, F E Boulton, R Doughty, et al.
Vox Sanguinis
|
June 8, 2006
Extended storage of platelets in SSP platelet additive solution
V S Hornsey, K McColl, O Drummond, et al.
Journal of Clinical Pathology
|
June 1, 1984
Platelet and coagulation factors in proliferative diabetic retinopathy
D Q Borsey, C V Prowse, R S Gray, et al.
Thrombosis and Haemostasis
|
October 1, 1981
Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate
C V Prowse, B Griffin, D S Pepper, et al.
Vox Sanguinis
|
January 1, 1988
Studies on the stability of VIII:C during the manufacture of a factor VIII concentrate for clinical use
P R Foster, I H Dickson, T A McQuillan, et al.
Page
of 10